Why is NIB Holdings Limited (ASX: NHF) doing so good?

NIB Holdings Limited – Kalkine Media

For the financial year ended 30 June 2018, unaudited Group Underlying Operating Profit will be approximately $184.0 million (against $165 million stated earlier), as per the FY18 update given by NIB Holdings Limited (ASX: NHF). The update represents a lift in the earnings guidance. The result also includes earnings from the acquisition of GU Health in October 2017 as indicated by the company.

[optin-monster-shortcode id=”wxhmli4jjedneglg1trq”]

‘Previous FY18 Group UOP guidance for NIB was a minimum of $165.0 million and a benign claims environment especially in its Australian resident’s health insurance business was the main factor behind the revised outlook’, the managing director said. NIB’s arhi business expects to pay $1.46 billion in claims in FY18 which is up by 4% on the previous year notwithstanding net organic membership growth of 3%, which excluded the impact of the GU Health acquisition in October 2017.

NIB Holdings Limited (ASX: NHF) is trading at a current market price of $6.245, up 9.6% on August 13, 2018 (2:50 PM AEST) with a performance change of -3.39% over the past 12 months while it rose 0.71% in the past 3 months.

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


Disclaimer

The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Checkout our Free Dividend Stocks Report

Specially made for income-hungry investors, Invest in growing Franked Dividends an opportunity that should not be missed.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report